Mar 07, 2022 / 07:50PM GMT
Max Masucci - Cowen and Company, LLC, Research Division - Senior Analyst
Good afternoon. Welcome to Cowen's 42nd Annual Health Care Conference. I'm Max Masucci from Cowen's Life Science and Diagnostic Tools Research Team. We're pleased to be joined today by Bruker, which is one of the 3 large cap names in our coverage and a diversified participant in several life science tools, diagnostics and other markets.
And joining us today is EVP and CFO, Gerald Herman. Gerald, great to see you.
Gerald N. Herman - Bruker Corporation - Executive VP, CFO & Corporate Controller
Great to see you. Thanks for the invitation.
Questions and Answers:
Max Masucci - Cowen and Company, LLC, Research Division - Senior AnalystAbsolutely. And for anybody on the line, feel free to lob in questions via the box at the bottom of the screen.
So let's jump in here. Life science tools and diagnostics industries, they've really exploded over the past half decade, initially driven by major breakthroughs in omic research,
Trustpilot
